Literature DB >> 8955069

Possible stimulation of retinal rod recovery to dark state by cGMP release from a cGMP phosphodiesterase noncatalytic site.

A Yamazaki1, V A Bondarenko, S Dua, M Yamazaki, J Usukura, F Hayashi.   

Abstract

Cyclic GMP phosphodiesterase, a key enzyme for phototransduction, contains alpha, beta (Palphabeta), and two gamma (Pgamma) subunits. In addition to catalytic sites, Palphabeta has two classes of noncatalytic cGMP binding sites with different affinities (Kd values <100 nM and >1 microM). Pgamma regulates Palphabeta as an inhibitor of cGMP hydrolysis and as a stimulator of cGMP binding to the high affinity noncatalytic sites. Pgamma release from Palphabeta by the GTP-bound alpha subunit of transducin (GTP.Talpha) interrupts these two functions. Here we describe a novel regulation of the Pgamma release by [cGMP] and its physiological implication. We isolated Pgamma mutants that exhibit abnormally one of these two functions, indicating the distinct domains in Pgamma are involved to express these functions. When [cGMP] was high ( approximately 5 microM), Pgamma responsible for the inhibition of cGMP hydrolysis was preferentially released, and cGMP hydrolysis activity of Palphabeta was increased about 10 times. When [cGMP] was low (less than approximately 0.5 microM), Pgamma responsible for the stimulation of cGMP binding to the high affinity sites was released. The Pgamma release resulted in the decrease of relative affinity of cGMP for the high affinity sites to at least (null)/1;10, followed by the rapid release of cGMP from one of the high affinity sites (apparent t1/2 = 3.8 s). cGMP ( approximately 5 microM) inhibited the extraction of Palphabeta from rod membranes by a Mg2+-free hypotonic buffer. The inhibition of Palphabeta extraction was not affected by Pgamma, suggesting that Palphabeta detects on the order of micromolar [cGMP] using low affinity noncatalytic sites on Palphabeta. Because [cGMP] is approximately 5 microM in darkness and lowered by photoexcitation and phosphodiesterase concentration is approximately 30 microM in rod photoreceptors, it is possible that cGMP phosphodiesterase functions to increase cytoplasamic [cGMP] after [cGMP] is reduced to the illuminated level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955069     DOI: 10.1074/jbc.271.51.32495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  A novel role of RGS9: inhibition of retinal guanylyl cyclase.

Authors:  Vladimir A Bondarenko; Hao Yu; Russell K Yamazaki; Akio Yamazaki
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Mechanism for the regulation of mammalian cGMP phosphodiesterase6. 2: isolation and characterization of the transducin-activated form.

Authors:  Akio Yamazaki; Masahiro Tatsumi; Vladimir A Bondarenko; Sadamu Kurono; Naoka Komori; Hiroyuki Matsumoto; Isao Matsuura; Fumio Hayashi; Russell K Yamazaki; Jiro Usukura
Journal:  Mol Cell Biochem       Date:  2010-02-23       Impact factor: 3.396

3.  Two temporal phases of light adaptation in retinal rods.

Authors:  Peter D Calvert; Victor I Govardovskii; Vadim Y Arshavsky; Clint L Makino
Journal:  J Gen Physiol       Date:  2002-02       Impact factor: 4.086

4.  Regulation of photoreceptor phosphodiesterase catalysis by its non-catalytic cGMP-binding sites.

Authors:  M R D'Amours; R H Cote
Journal:  Biochem J       Date:  1999-06-15       Impact factor: 3.857

5.  Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A.

Authors:  S H Soderling; S J Bayuga; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Cloning and characterization of two splice variants of human phosphodiesterase 11A.

Authors:  J M Hetman; N Robas; R Baxendale; M Fidock; S C Phillips; S H Soderling; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Onset of feedback reactions underlying vertebrate rod photoreceptor light adaptation.

Authors:  P D Calvert; T W Ho; Y M LeFebvre; V Y Arshavsky
Journal:  J Gen Physiol       Date:  1998-01       Impact factor: 4.086

8.  Binding of cGMP to the transducin-activated cGMP phosphodiesterase, PDE6, initiates a large conformational change involved in its deactivation.

Authors:  Akio Yamazaki; Fumio Hayashi; Isao Matsuura; Vladimir A Bondarenko
Journal:  FEBS J       Date:  2011-04-20       Impact factor: 5.542

9.  Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei.

Authors:  Ana Rascón; Scott H Soderling; Jonathan B Schaefer; Joseph A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

10.  Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A.

Authors:  L Fawcett; R Baxendale; P Stacey; C McGrouther; I Harrow; S Soderling; J Hetman; J A Beavo; S C Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.